Lawrence Biegelsen
Stock Analyst at Wells Fargo
(1.87)
# 3,231
Out of 5,002 analysts
55
Total ratings
57.14%
Success rate
-4.43%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lawrence Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Maintains: Equal-Weight | $172 → $184 | $191.60 | -3.97% | 5 | Aug 8, 2025 | |
| PODD Insulet | Maintains: Overweight | $330 → $350 | $312.21 | +12.10% | 5 | Aug 8, 2025 | |
| ABT Abbott Laboratories | Maintains: Overweight | $147 → $142 | $132.99 | +6.77% | 8 | Jul 18, 2025 | |
| NPCE NeuroPace | Upgrades: Overweight | $16 → $20 | $10.43 | +91.75% | 7 | Mar 14, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $166 → $82 | $13.11 | +525.48% | 5 | Aug 4, 2022 | |
| TFX Teleflex | Downgrades: Equal-Weight | $248 | $125.50 | +97.61% | 1 | Jul 29, 2022 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $350 → $339 | $443.01 | -23.48% | 2 | Apr 22, 2022 | |
| REE REE Automotive | Initiates: Underweight | $1.5 | $0.76 | +97.29% | 1 | Mar 25, 2022 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $55 → $27 | $1.69 | +1,497.63% | 3 | Feb 24, 2022 | |
| ZBH Zimmer Biomet Holdings | Maintains: Underweight | $124 → $111 | $99.17 | +11.93% | 2 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $144 | $66.44 | +116.36% | 1 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $56 | $84.49 | -33.72% | 4 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $68 → $74 | $82.46 | -10.26% | 6 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $77 | $76.65 | +0.03% | 3 | Apr 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $85 → $90 | $14.05 | +540.57% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $58.06 | - | 1 | Dec 12, 2019 |
Becton, Dickinson and Company
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $172 → $184
Current: $191.60
Upside: -3.97%
Insulet
Aug 8, 2025
Maintains: Overweight
Price Target: $330 → $350
Current: $312.21
Upside: +12.10%
Abbott Laboratories
Jul 18, 2025
Maintains: Overweight
Price Target: $147 → $142
Current: $132.99
Upside: +6.77%
NeuroPace
Mar 14, 2024
Upgrades: Overweight
Price Target: $16 → $20
Current: $10.43
Upside: +91.75%
Tandem Diabetes Care
Aug 4, 2022
Maintains: Overweight
Price Target: $166 → $82
Current: $13.11
Upside: +525.48%
Teleflex
Jul 29, 2022
Downgrades: Equal-Weight
Price Target: $248
Current: $125.50
Upside: +97.61%
Intuitive Surgical
Apr 22, 2022
Maintains: Overweight
Price Target: $350 → $339
Current: $443.01
Upside: -23.48%
REE Automotive
Mar 25, 2022
Initiates: Underweight
Price Target: $1.5
Current: $0.76
Upside: +97.29%
Pulmonx
Feb 24, 2022
Maintains: Equal-Weight
Price Target: $55 → $27
Current: $1.69
Upside: +1,497.63%
Zimmer Biomet Holdings
Feb 8, 2022
Maintains: Underweight
Price Target: $124 → $111
Current: $99.17
Upside: +11.93%
Jan 19, 2022
Upgrades: Overweight
Price Target: $144
Current: $66.44
Upside: +116.36%
Jan 19, 2022
Upgrades: Equal-Weight
Price Target: $56
Current: $84.49
Upside: -33.72%
Oct 29, 2021
Maintains: Equal-Weight
Price Target: $68 → $74
Current: $82.46
Upside: -10.26%
Apr 28, 2020
Downgrades: Equal-Weight
Price Target: $77
Current: $76.65
Upside: +0.03%
Mar 5, 2020
Upgrades: Overweight
Price Target: $85 → $90
Current: $14.05
Upside: +540.57%
Dec 12, 2019
Upgrades: Overweight
Price Target: n/a
Current: $58.06
Upside: -